Results 201 to 210 of about 88,336 (262)

Effects of calcium channel blockers in patients with heart failure with preserved ejection fraction: A protocol for systematic review and meta-analysis. [PDF]

PLoS One
Fukuta H, Goto T, Kamiya T.
europepmc   +1 more source

Effects of calcium channel blockers in patients with heart failure with preserved and mildly reduced ejection fraction: A systematic review and meta-analysis. [PDF]

Int J Cardiol Heart Vasc
Fukuta H, Goto T, Kamiya T.
europepmc   +1 more source

Examining the therapeutic potential and side effects of calcium channel blockers in mortality and morbidity of patients with stroke: A systematic review of pre-clinical and clinical studies. [PDF]

IBRO Neurosci Rep
Hatamian S, Abdi A, Asl FSS, Tafazolimoghadam A, Tavasol A, Nejad SAM, Madadi R, Tajabadi Z, Dehghani M, Ahmadpoor N, Fathi M, Hajiesmaeili M, Nooraei N.   +12 more
europepmc   +1 more source

Real-world efficacy of fimasartan vs. other angiotensin receptor blockers in combination with calcium channel blockers: a nationwide cohort study. [PDF]

Clin Hypertens
Lee H, Park CS, Kim B, Rhee TM, Lee H, Kim YJ, Han K, Kim HK.   +7 more
europepmc   +1 more source

Do calcium channel blockers applied to cardiomyocytes cause increased channel expression resulting in reduced efficacy? [PDF]

NPJ Syst Biol Appl
Jæger KH, Charwat V, Wall S, Healy KE, Tveito A.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Calcium channel blockers: an update

The American Journal of Medicine, 2004
This paper reviews the current literature pertaining to calcium channel blockers, including their classification, properties, and therapeutic indications, in light of several recent trials that have addressed their safety. Calcium channel blockers are a structurally and functionally heterogeneous group of medications that are used widely to control ...
Mark J, Eisenberg, Anya, Brox, Alain N, Bestawros   +2 more
openaire   +2 more sources

Calcium Channel Blocker Toxicity

Pediatric Emergency Care, 2009
Calcium channel blockers continue to be used for the management of a wide variety of adult and pediatric conditions including hypertension, angina pectoris, atrial arrhythmias, Raynaud phenomenon, and migraine headaches. With increased use comes increased potential for misuse and abuse.
Anna Maria, Arroyo, Louise W, Kao
openaire   +2 more sources

Calcium Channel Blockers

AACN Advanced Critical Care, 1992
Calcium channel blockers are widely used in the treatment of ischemic heart disease, hypertension, and supraventricular tachycardia. The prototype agents, verapamil, nifedipine, and diltiazem, represent three classes of calcium channel blockers, each of which has different pharmacologic effects.
openaire   +2 more sources

Differentiation of Calcium Entry Blockers into Calcium Channel Blockers and Calcium Overload Blockers

European Neurology, 2008
The heterogeneity of the several subgroups of calcium-antagonistic drugs requires a rigid and well-defined differentiation of this type of agents. From the chemical point of view verapamil-like drugs, dihydrophyridines, benzothiazepines and diphenylalkylamines should be distinguished. Among these largely different groups no obvious relationship between
openaire   +2 more sources